Is an Upper Respiratory Infection Viral or Bacterial?

The vast majority of upper respiratory infections are viral. In studies that test for specific pathogens, viruses account for roughly 80 to 85 percent of cases, with bacteria responsible for a much smaller fraction. That lopsided ratio holds across age groups, seasons, and geographic settings, yet antibiotics still get prescribed for URIs at remarkably high rates. The mismatch between the biology and the treatment persists partly because telling the two apart at the bedside is harder than most people assume.

The Numbers Behind the Split

When researchers use molecular testing to identify what is actually causing upper respiratory symptoms, the results are consistent. One study of patients presenting with fever and flu-like illness found that among those who tested positive for a pathogen, about 82 percent had purely viral infections, while only about 12 percent had bacteria alone. Another roughly 7 percent had both a virus and a bacterium at the same time.¹ A similar picture emerges in young children with acute respiratory illness, where viruses or atypical bacteria were detected in about 86 percent of cases, with respiratory syncytial virus, adenovirus, and rhinovirus topping the list.²

The viruses you are most likely to encounter include rhinoviruses (the leading cause of the common cold), influenza, parainfluenza, respiratory syncytial virus, adenoviruses, and coronaviruses, including but not limited to SARS-CoV-2. These pathogens spread through respiratory droplets and contact with contaminated surfaces, and they cause the sore throat, runny nose, cough, and congestion that most people recognize as a “cold” or “upper respiratory infection.” The bacterial agents that occasionally cause primary URIs or co-infect alongside a virus include Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Bordetella pertussis, though their solo role is comparatively small.

Why Symptoms Alone Cannot Tell You the Cause

One of the most persistent misconceptions is that green or yellow mucus means you have a bacterial infection, while clear mucus means viral. Research does not support that shortcut. A systematic review looking at acute rhinosinusitis specifically concluded that purulent (thick, colored) nasal discharge does not reliably distinguish bacterial from viral causes, and treatment decisions should not hinge on its presence.³ Colored mucus typically reflects the activity of your immune cells, not the type of pathogen they are fighting.

The same problem extends to other symptoms. A study of community-acquired pneumonia patients, where the stakes of misidentification are higher, found that although some signs were statistically linked to either viral or bacterial causes, the overlap was so large that no combination of symptoms reliably predicted one over the other. The researchers concluded that laboratory testing remained necessary to guide treatment.⁴ In short, a doctor looking at you across the exam room cannot confidently declare “this is bacterial” based on how you look and feel.

The typical viral URI follows a recognizable arc. Symptoms begin within about 10 to 16 hours of infection, peak around days two to three, and last roughly a week, though about a quarter of cases drag on longer.⁵ A sudden worsening after initial improvement, or symptoms that persist well past 10 days without getting better, can raise suspicion of a secondary bacterial process, but even these patterns are guidelines rather than certainties.

The Sore Throat Exception

Sore throat deserves its own discussion because it is one of the few upper respiratory symptoms where bacterial testing is both practical and recommended. Group A Streptococcus (strep throat) is the primary bacterial target, and it genuinely benefits from antibiotic treatment, both to shorten the illness and to prevent rare but serious complications like rheumatic fever. Joint guidance from the American College of Physicians and the CDC advises testing with a rapid antigen detection test or throat culture when certain features are present: persistent fever, tender swollen lymph nodes at the front of the neck, and pus or white patches on the tonsils. Antibiotics should be given only after strep is confirmed, not based on clinical suspicion alone.⁶

Clinicians sometimes use clinical scoring tools like the Centor score to estimate the likelihood of strep before deciding whether to test. The score adds points for tonsillar exudates, swollen anterior lymph nodes, fever history, and absence of cough. A systematic review found that using a score of 3 or higher as the threshold for considering antibiotics had reasonable specificity but yielded a post-test probability of strep ranging from only 12 to 40 percent depending on how common strep was in the local population.⁷ A separate analysis found the overall diagnostic accuracy of the Centor score and another tool called FeverPAIN to be poor, with area-under-the-curve values around 0.6 for both.⁸ The clinical scores are useful for deciding who to test, but they are not a substitute for the test itself.

Sinus Infections and Ear Infections

Acute rhinosinusitis, the condition most people call a “sinus infection,” follows a similar viral-first pattern. Most cases begin as part of a viral cold and resolve on their own. The same ACP/CDC guidance reserves antibiotics for three specific scenarios: symptoms lasting more than 10 days without improvement; severe symptoms like high fever above 39°C with purulent discharge or facial pain lasting at least three consecutive days; or a pattern called “double sickening,” where symptoms initially improve and then get worse again around day five.⁶ Outside those windows, antibiotics are unlikely to help and carry real downsides.

Ear infections, particularly acute otitis media in children, sit at an interesting crossroads. The infection often begins when a viral cold disrupts the normal function of the Eustachian tube, the small channel connecting the middle ear to the back of the throat. The virus causes swelling and impairs the tube’s ability to drain, which allows bacteria that normally live harmlessly in the nose and throat to migrate into the middle ear and multiply.⁹ So a child’s ear infection is often viral and bacterial at the same time. Despite this, antibiotic treatment does not significantly benefit most children with acute otitis media, though it can help in recurrent or severe cases.¹⁰

What Blood Tests and Biomarkers Can Do

Doctors sometimes order blood work to help distinguish bacterial from viral infections, especially when the diagnosis is not straightforward. The most commonly used markers are C-reactive protein (CRP), white blood cell count, and procalcitonin (PCT). Bacterial infections tend to drive all three higher than viral infections do. One retrospective study found that median CRP was about 69 mg/L in bacterial respiratory infections versus about 20 mg/L in viral ones, and a combination of white blood cell count, neutrophils, monocytes, and CRP achieved an area under the curve of roughly 0.76 for distinguishing the two.¹¹

Those numbers sound useful, but they come with a significant caveat. The overlap between bacterial and viral values is large enough that any single marker can mislead. Procalcitonin, which has been widely promoted as a bacterial infection indicator, runs into the same problem in practice. A scoping review of procalcitonin in children with respiratory infections found that while levels were generally higher with bacterial causes, there was enough overlap that the marker was not highly accurate for distinguishing the two groups, especially in severely ill children requiring intensive care.¹² Blood markers are a piece of the puzzle, not the answer by themselves.

Newer Approaches to Telling Them Apart

Researchers have been working on better rapid tests that can distinguish viral from bacterial infections at the point of care, ideally in the same visit. One promising approach combines measurement of MxA, a protein your cells ramp up when fighting a virus, with CRP, which rises more with bacterial infections. A point-of-care test using this combination correctly identified about 80 percent of bacterial infections and 70 percent of viral infections in one evaluation.¹³ A larger outpatient study of a similar bacterial-and-viral biomarker test found it correctly classified about 93 percent of bacterial infections and about 70 percent of viral infections, with a very high negative predictive value, meaning that when the test said “not bacterial,” it was right about 99 percent of the time.¹⁴

Another avenue involves measuring MxA expression on monocytes, a specific type of white blood cell. In one prospective study of adults, monocyte MxA levels were sharply higher in viral infections compared to bacterial ones, achieving an area under the curve of 0.9 for distinguishing the two, with sensitivity and specificity both above 84 percent.¹⁵ These tools are still working their way into routine clinical use, but they represent a real improvement over relying on symptoms or CRP alone.

Multiplex PCR panels, which can test a nasal swab for dozens of viruses and bacteria simultaneously, offer a different approach entirely. Rather than measuring the body’s response, they detect the pathogen’s genetic material directly. A meta-analysis found these panels deliver very high accuracy for influenza A, influenza B, RSV, and human metapneumovirus, with areas under the curve at 0.98 or above for most targets.¹⁶ These panels are increasingly available, especially in emergency departments and urgent care settings, and can identify a specific virus within an hour or two. The drawback is that detecting a pathogen’s DNA does not always mean it is the cause of the current illness. People, especially young children, can carry respiratory viruses or bacteria without symptoms, so a positive result needs to be interpreted alongside the clinical picture.

Why Antibiotics Still Get Prescribed

If the evidence so strongly favors a viral cause for most URIs, why do so many patients walk out of the clinic with an antibiotic prescription? Part of the answer is patient expectation. A mixed methods study found that people who believed antibiotics effectively treat colds and flu were significantly more likely to expect or demand a prescription. Younger adults, people who had not attended university, and non-native English speakers were also more likely to expect antibiotics. Conversely, people who knew that antibiotics do not kill viruses and that unnecessary use drives resistance were less likely to push for them.¹⁷

Clinician behavior is the other half of the equation. Diagnostic uncertainty, time pressure, and the desire to “do something” for a symptomatic patient all push toward prescribing. Acute upper respiratory infections account for a large share of urgent care visits, and most of these visits do not warrant antibiotics.¹⁸ Stewardship interventions, where clinics adopt structured protocols that include offering a symptom-relief prescription as an alternative to antibiotics, have shown real success. One such program saw antibiotic prescribing for acute bronchitis drop from about 37 percent to 18 percent when clinicians offered a supportive care prescription instead.¹⁹

The Real Harm of Unnecessary Antibiotics

Taking antibiotics when they are not needed is not a neutral event. Beyond the familiar risks of allergic reactions and diarrhea, antibiotics reshape the community of microbes living in your gut and airways. This disruption can reduce microbial diversity, promote the growth of antibiotic-resistant strains, and increase vulnerability to infections like Clostridioides difficile, a bacterium that causes severe intestinal illness.²⁰

There is growing evidence that the effects extend beyond the gut. Animal research has shown that antibiotics that reduce beneficial gut bacteria like Lactobacillus and Bifidobacterium while encouraging harmful species can worsen outcomes from influenza virus infection through immune pathways connected to the gut.²¹ In other words, taking an antibiotic for a viral URI might not just fail to help; it could theoretically leave you more susceptible to the next respiratory infection. The evidence here is still being built, but the direction of the findings reinforces the case for restraint.

When a Viral URI Leads to a Bacterial Problem

Even though most URIs are viral from start to finish, the virus can set the stage for a secondary bacterial infection. This is the classic story of “I had a cold, and then it turned into pneumonia.” Viral infection damages the lining of the airways, impairs the immune response, and disrupts normal clearance of mucus and debris. That creates an opening for bacteria that are already present in the nose and throat to invade deeper tissue.²² The same virus-then-bacteria sequence drives many ear infections, as described earlier with the Eustachian tube mechanism.

This progression is worth understanding because it reframes the question slightly. It is not always a matter of “was this viral or bacterial?” but sometimes “did this start viral and then acquire a bacterial component?” The warning signs of secondary bacterial infection include a new fever after you had started to improve, worsening symptoms after a brief period of recovery, and shortness of breath or chest pain that was not present at the onset. These are the situations where prompt medical evaluation and possible antibiotic use become genuinely important.

Seasonal Patterns and Co-Infection

Respiratory viruses and the bacteria that sometimes complicate them follow distinct seasonal rhythms. Viruses like influenza and RSV peak in winter, while certain bacteria show their own seasonal variation. One analysis found that Streptococcus pneumoniae detections tracked alongside circulating respiratory viruses, reinforcing the biological link between viral colds and secondary bacterial involvement.²³ That seasonal overlap helps explain why bacterial complications of viral URIs cluster during winter as well.

Co-detection of viruses and bacteria in the same patient is common, especially in young children. A study of children under five with cough found that co-detection was significantly more likely in children under two years old, boys, those attending daycare, and those enrolled during winter months.²⁴ Interpreting co-detection is tricky: finding both a virus and a bacterium in a nose swab does not necessarily mean both are causing illness. Infants routinely carry potential bacterial pathogens in their upper airways without being sick from them.²⁵ The presence of bacteria alone is not proof of bacterial infection, which is one more reason that diagnosis requires more than a lab printout.

Older Adults and Atypical Presentations

Upper respiratory infections in older adults can behave differently. Elderly patients are more likely to present with atypical symptoms, sometimes without the classic sore throat and runny nose and instead showing confusion, worsened chronic conditions, or general decline.²⁶ This atypical presentation can delay diagnosis, lead to unnecessary drug prescriptions, and increase the risk of progression to lower respiratory infections or pneumonia. For older adults and their caregivers, any noticeable change in baseline function during cold and flu season is worth a medical conversation, even without the hallmark URI symptoms.

The immune system also changes with age in ways that blur the viral-bacterial line. Older adults clear viruses more slowly, giving bacteria a longer window to establish secondary infections. They are also more likely to have chronic lung conditions that predispose them to bacterial complications. None of this changes the fundamental answer, most URIs are still viral, but it does shift the risk calculus. What would be a simple cold in a 30-year-old can become a more complex illness in a person over 70, and the threshold for seeking care should be lower.